Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

54 results about "Pcr diagnosis" patented technology

PCR tests diagnose calicivirus infections present in the sample by detecting the genetic sequence of certain strains of bacteria. This method of testing is considered more effective in comparison to antibody tests, as diagnosis doesn't depend on increased levels of antibodies in the blood.

Variant porcine reproductive and respiratory syndrome virus (PRRSV) TaqMan fluorescence quantitative RT-PCR detecting kit and application thereof

The invention discloses variant porcine reproductive and respiratory syndrome virus (PRRSV) TaqMan fluorescence quantitative RT-PCR detecting kit and application thereof. A primer and a TaqMan probe are designed and synthesized by referring to an NSP2 fragment gene sequence of the variant PRRSV and common PRRSV of a GenBank. By optimizing the reaction condition and constructing a standard plasmid product, a method for diagnosing the variant PRRSV by TaqMan fluorescence quantitative RT-PCR is established. A result indicates that the method has the advantages of strong specificity, high sensitivity, and the like and can detect the standard plasmid product with 264 copy numbers, and the virus quantity of 0.5623TICD50 is 10 times more sensitive than RT-PCR. By detecting 22 disease samples, 8 disease samples are positive, and the positive rate is 36.4 percent. Because the method has the advantages of quantification, high speed, accuracy, sensitivity, and the like, the invention is suitable for the diagnosis on the swinery infected variant PRRSV in the early stage, the medium stage and the later stage and plays an important role in effectively diagnosing, preventing and treating the highly pathogenic PRRSV.
Owner:INST OF ANIMAL HUSBANDRY & VETERINARY FUJIAN ACADEMY OF AGRI SCI +6

Kit for detecting ERCC1 mRNA (Excision Repair Cross Complement Group 1 Messenger Ribonucleic Acid) expression by using fluorescence quantitative PCR (Polymerase Chain Reaction) technology

The invention relates to the field of biotechnology, discloses a fluorescence quantitative PCR (Polymerase Chain Reaction) diagnostic kit for rapidly detecting ERCC1 mRNA (Excision Repair Cross Complement Group 1 Messenger Ribonucleic Acid), and aims to provide a kit capable of rapidly, conveniently, sensitively and specifically detecting ERCC1 mRNA and application thereof. An expression status of a DNA (Deoxyribonucleic Acid) repair gene can be used as a relatively ideal predictor for a chemotherapeutic effect. Nucleotide excision repair (NER) is in close relation with platinum drug resistance, wherein the excision repair cross complement group 1 (ERCC1) is an important factor which plays a role in a repair process and causes platinum drug resistance; the ERCC1 mRNA level is detected by using higher-sensitivity and higher-specificity fluorescence quantitative PCR; and the specificity and the sensitivity of a detection result are obviously improved. The kit provides a completely new rapid and convenient gene diagnosis technology for use of platinum type chemotherapeutic medicaments of clinical malignant tumor patients.
Owner:SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY

HPV detection kit

The invention discloses a qPCR primer for detecting HPVs. The qPCR primer comprises the following primer pairs of two types: the primer pairs of the first type are capable of amplifying conserved sequences in the HPV genomes of all the types; the primer pairs of the second type are capable of detecting the HPVs of at least two types in the same tubular qPCR system. The invention also discloses an HPV detection kit comprising the primer pairs. The HPV detection kit is high in HPV detection specificity and completely reaches the specificity level of qPCR by use of a probe method. Compared with traditional PCR diagnosis, the HPV detection kit is simpler and more reliable to operate, and meanwhile, applicable to high-throughput sample detection. The HPV detection kit further has the characteristics of high specificity, strong sensitivity and low cost by applying a double-stranded DNA combined fluorochrome qPCR detection method to the diagnosis of the HPVs; as a result, a quick and accurate molecular detection method is provided for general investigation of the HPVs and prevention and treatment of the cervical cancer, and meanwhile, the test cost is greatly reduced; in short, the HPV detection kit has an important popularization and application value.
Owner:镇江爱必梦生物科技有限公司

One-step RT-PCR diagnostic kit for identifying porcine epidemic diarrhea virus vaccine attenuated strain and/or prevalent strain

The invention provides a one-step RT-PCR diagnostic kit for identifying a porcine epidemic diarrhea virus vaccine attenuated strain and/or prevalent strain. The one-step RT-PCR diagnostic kit comprises 20muL of RT-PCR one-step enzyme, 250muL of a enzyme buffer solution, 300muL of RNase Free dH2O, 40muL of a mixed primer, 20muL of positive control, 20muL of negative control, 80muL of DL2000 and 25muL of 6*Loading Buffer. Compared with the prior art, the kit has the advantages that the operation is simple, inverse transcription and PCR amplification are completed in one step, the reaction time is shortened, degradation of a template RNA is avoided and the detection sensitivity is improved. The amplification results of the primer on porcine transmissible gastroenteritis virus, group A swine rotavirus, classical swine fever virus, porcine reproductive and respiratory syndrome virus and porcine teschovirus are all negative. According to the method, 1pg porcine epidemic diarrhea virus vaccine attenuated strain and 1pg prevalent strain can be detected to the minimum extent; the kit can be widely applied to basic-level detection mechanisms and is of great significance in early differential diagnosis, control and purification of epidemic diarrhea virus diseases on a pig farm.
Owner:SHANDONG BINZHOU ANIMAL SCI & VETERINARY MEDICINE ACADEMY

Kit for detecting mRNA expression quantity of M BCR fusion gene

The invention relates to a fluorescent quantitative PCR (Polymerase Chain Reaction) diagnosis kit for detecting mRNA of an M BCR fusion gene, belonging to the field of biotechnology. The kit comprises a detection primer, a fluorescent probe, a cDNA first-chain synthesis reagent, a fluorescent quantitative PCR mixed liquor, negative control and positive control, wherein the detection primer and the fluorescent probe comprise an M BCR gene primer, a reference gene ABL primer and a Taqman fluorescent probe. The kit can effectively detect the M BCR fusion gene forms, such as e14a3, e13a3, e14a2 and e13a2. The M BCR fusion gene is a gene mark of malignant clone of pluripotential hemopoietic stem cells, is a typical molecular marker of chronic granulocytic leukemia and is related to inhibition of the apoptosis of the leukemic cell. The fluorescent quantitative PCR technology with higher sensitivity and specificity is used for detecting the mRNA level of the M BCR gene, and the specificity and the sensitivity of the detection result both are improved remarkably. The kit provided by the invention provides a brand-new rapid, simple and convenient gene diagnosis technology for making a therapeutic regimen for the patients with chronic granulocytic leukemia, and predicting prognosis.
Owner:李艳 +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products